PriceTargets.com logo

Owens & Minor - OMI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $6.35
  • Forecasted Upside: 149.41%
  • Number of Analysts: 8
  • Breakdown:
  • 4 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$2.55 As of 12/4/2025 04:59 PM ET
▼ -0.054 (-2.08%)

This chart shows the closing price for OMI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Owens & Minor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OMI

Analyst Price Target is $6.35
▲ +149.41% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Owens & Minor in the last 3 months. The average price target is $6.35, with a high forecast of $7.00 and a low forecast of $4.75. The average price target represents a 149.41% upside from the last price of $2.55.

This chart shows the closing price for OMI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 8 polled investment analysts is to hold stock in Owens & Minor. This rating has held steady since July 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 3 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 4 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 4 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/10/2025Zacks ResearchDowngradeHold ➝ Strong Sell
10/10/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/2/2025Zacks ResearchDowngradeHold ➝ Strong Sell
8/27/2025JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$7.00 ➝ $6.00
8/13/2025UBS GroupSet Target$7.00
8/12/2025CitigroupReiterated RatingBuy ➝ Buy$11.00 ➝ $7.00
8/12/2025Bank of AmericaLower TargetUnderperform ➝ Underperform$7.50 ➝ $4.75
8/12/2025Robert W. BairdLower TargetOutperform ➝ Outperform$10.00 ➝ $7.00
8/11/2025JPMorgan Chase & Co.Set Target$10.00
8/11/2025UBS GroupLower TargetBuy ➝ Buy$13.00 ➝ $7.00
8/8/2025Robert W. BairdSet Target$10.00
8/8/2025Baird R WUpgradeHold ➝ Strong-Buy
6/6/2025Robert W. BairdBoost TargetNeutral ➝ Neutral$9.00 ➝ $10.00
4/17/2025CitigroupLower TargetBuy ➝ Buy$13.00 ➝ $11.00
3/10/2025JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$14.00 ➝ $10.00
3/3/2025Robert W. BairdBoost TargetNeutral ➝ Neutral$10.00 ➝ $11.00
2/25/2025Robert W. BairdLower TargetNeutral ➝ Neutral$14.00 ➝ $10.00
2/13/2025UBS GroupLower TargetBuy ➝ Buy$25.00 ➝ $13.00
2/4/2025Robert W. BairdLower TargetNeutral ➝ Neutral$15.00 ➝ $14.00
11/5/2024UBS GroupLower TargetBuy ➝ Buy$28.00 ➝ $25.00
11/5/2024CitigroupLower TargetBuy ➝ Buy$21.00 ➝ $18.50
11/5/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$18.00 ➝ $14.00
11/5/2024Robert W. BairdLower TargetNeutral ➝ Neutral$19.00 ➝ $14.00
8/21/2024JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$22.00 ➝ $18.00
8/5/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $18.00
7/19/2024CitigroupUpgradeNeutral ➝ Buy$24.00 ➝ $19.00
7/16/2024Robert W. BairdLower TargetNeutral ➝ Neutral$20.00 ➝ $19.00
6/25/2024Bank of AmericaLower TargetUnderperform ➝ Underperform$18.00 ➝ $16.00
6/25/2024Robert W. BairdLower TargetNeutral ➝ Neutral$24.00 ➝ $20.00
5/6/2024Robert W. BairdLower TargetNeutral ➝ Neutral$28.00 ➝ $24.00
4/30/2024CitigroupBoost TargetNeutral ➝ Neutral$24.00 ➝ $28.00
4/10/2024Robert W. BairdBoost TargetNeutral ➝ Neutral$24.00 ➝ $28.00
2/26/2024Leerink PartnrsReiterated RatingMarket Perform
2/26/2024Leerink PartnersInitiated CoverageMarket Perform$24.00
2/21/2024CitigroupBoost TargetNeutral ➝ Neutral$23.00 ➝ $24.00
2/21/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00
1/29/2024UBS GroupLower TargetBuy ➝ Buy$28.00 ➝ $26.00
1/3/2024BarclaysInitiated CoverageEqual Weight$21.00
12/8/2023UBS GroupBoost TargetBuy ➝ Buy$22.00 ➝ $28.00
11/17/2023JPMorgan Chase & Co.Lower TargetUnderweight ➝ Underweight$21.00 ➝ $19.00
8/8/2023Credit Suisse GroupBoost TargetNeutral ➝ Neutral$18.00 ➝ $19.00
8/4/2023CitigroupLower Target$23.00 ➝ $21.00
5/8/2023UBS GroupBoost Target$22.00 ➝ $24.00
5/8/2023Robert W. BairdBoost Target$18.00 ➝ $21.00
3/8/2023CitigroupLower TargetNeutral$20.00 ➝ $17.00
3/7/2023Credit Suisse GroupLower TargetNeutral$20.00 ➝ $17.00
3/1/2023Robert W. BairdLower TargetNeutral$23.00 ➝ $18.00
11/3/2022CitigroupBoost TargetNeutral$18.00 ➝ $20.00
10/14/2022Credit Suisse GroupLower TargetHold Neutral$37.00 ➝ $20.00
10/13/2022CitigroupDowngradeBuy ➝ Neutral$52.00 ➝ $18.00
10/12/2022Bank Of America (Bofa)DowngradeBuy ➝ Underperform$43.00 ➝ $17.00
10/12/2022Bank of AmericaDowngradeBuy ➝ Underperform$43.00 ➝ $17.00
10/12/2022Robert W. BairdDowngradeOutperform ➝ Neutral$62.00 ➝ $22.00
8/4/2022Credit Suisse GroupLower TargetNeutral$43.00 ➝ $37.00
8/4/2022Robert W. BairdLower TargetOutperform$70.00 ➝ $62.00
8/4/2022CitigroupLower Target$58.00 ➝ $52.00
5/16/2022CitigroupBoost TargetNA$58.00
4/26/2022CitigroupInitiated CoverageBuy
2/28/2022Credit Suisse GroupBoost TargetNeutral$42.00 ➝ $43.00
12/17/2021CitigroupUpgradeNeutral ➝ Buy$55.00
8/4/2021Credit Suisse GroupLower TargetNeutral$43.00 ➝ $42.00
5/27/2021Robert W. BairdBoost TargetBuy ➝ Outperform$52.00 ➝ $55.00
5/27/2021CitigroupBoost TargetNeutral$39.00 ➝ $46.00
5/11/2021Credit Suisse GroupBoost TargetNeutral$34.00 ➝ $38.00
3/26/2021Robert W. BairdUpgradeOutperform$45.00 ➝ $50.00
2/25/2021BarclaysBoost TargetEqual Weight$23.00 ➝ $33.00
12/17/2020UBS GroupUpgradeNeutral ➝ Buy$27.00 ➝ $37.00
12/11/2020Smith Barney CitigroupInitiated CoverageNeutral$30.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.25 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 19 very positive mentions
  • 17 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/8/2025
  • 22 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
6/7/2025
  • 5 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 22 very positive mentions
  • 18 positive mentions
  • 8 negative mentions
  • 2 very negative mentions
Mentions as of
9/5/2025
  • 10 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 8 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 7 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 7 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Owens & Minor logo
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.
Read More

Today's Range

Now: $2.55
Low: $2.45
High: $2.60

50 Day Range

MA: $3.91
Low: $2.55
High: $5.51

52 Week Range

Now: $2.55
Low: $2.45
High: $15.54

Volume

2,376,835 shs

Average Volume

1,777,054 shs

Market Capitalization

$196.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Frequently Asked Questions

What sell-side analysts currently cover shares of Owens & Minor?

The following Wall Street analysts have issued research reports on Owens & Minor in the last twelve months: Baird R W, Bank of America Corporation, Citigroup Inc., JPMorgan Chase & Co., Robert W. Baird, UBS Group AG, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for OMI.

What is the current price target for Owens & Minor?

0 Wall Street analysts have set twelve-month price targets for Owens & Minor in the last year. Their average twelve-month price target is $6.35, suggesting a possible upside of 149.4%. UBS Group AG has the highest price target set, predicting OMI will reach $7.00 in the next twelve months. Bank of America Corporation has the lowest price target set, forecasting a price of $4.75 for Owens & Minor in the next year.
View the latest price targets for OMI.

What is the current consensus analyst rating for Owens & Minor?

Owens & Minor currently has 4 sell ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OMI, but not buy more shares or sell existing shares.
View the latest ratings for OMI.

What other companies compete with Owens & Minor?

Other companies that are similar to Owens & Minor include Henry Schein, McKesson, Cencora, Cardinal Health and Valneva. Learn More about companies similar to Owens & Minor.

How do I contact Owens & Minor's investor relations team?

Owens & Minor's physical mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company's listed phone number is (804) 723-7000 and its investor relations email address is [email protected]. The official website for Owens & Minor is www.owens-minor.com. Learn More about contacing Owens & Minor investor relations.